Oxygenta Pharmaceutical Ltd - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And All Other Applicable Regulations.

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the company will be held on Thursday, 30th May 2024, inter alia, to consider the Audited financial results of the Company for the Fourth quarter and Financial Year ended on 31st March, 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015. In continuation to our earlier intimation of closure of trading window, we would like to inform that the trading window of the Company for all the designated persons and their immediate relatives will remain closed till 01st June, 2024, which is 48 hours after the said Board Meeting. This is for your information and records.